ESC Professional Premium Access

The management challenge of atrial fibrillation in HFrEF and HFpEF

Event: ESC Congress 2022
Topic: Pathophysiology and Mechanisms
Session type: Symposium
Date: 29 August 2022
Time: 08:30 - 10:00

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

Atrial fibrillation and heart failure: epidemiology, risk factors and prevention.

Speaker: Professor L. Kober (Copenhagen, DK)
Thumbnail

Rate control first for most atrial fibrillation patients: beta-blocker and/or digitalis?

Speaker: Professor D. Kotecha (Birmingham, GB)
Thumbnail

How good is pulmonary vein isolation in atrial fibrillation with heart failure?

Speaker: Associate Professor T. Potpara (Belgrade, RS)
Thumbnail

Atrioventricular node ablation and CRT is the future.

Speaker: Professor G. Hindricks (Leipzig, DE)
Thumbnail

The management challenge of atrial fibrillation in HFrEF and HFpEF – discussion.

Speaker: Doctor E. O'Meara (Montreal, CA)
Thumbnail

5 speakers from this session

Professor Lars Kober

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
17 presentations
0 follower

Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
27 presentations
0 follower

Associate Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)
33 presentations
1 follower

Professor Gerhard Hindricks

Heart Center of Leipzig, Leipzig (Germany)
57 presentations
16 followers

Doctor Eileen O'Meara

Montreal Heart Institute, Montreal (Canada)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk